218 related articles for article (PubMed ID: 10090164)
1. Circulating levels of beta-chemokines in systemic lupus erythematosus.
Kaneko H; Ogasawara H; Naito T; Akimoto H; Lee S; Hishikawa T; Sekigawa I; Tokano Y; Takasaki Y; Hirose SI; Hashimoto H
J Rheumatol; 1999 Mar; 26(3):568-73. PubMed ID: 10090164
[TBL] [Abstract][Full Text] [Related]
2. [Correlation of chemokines and chemokine receptors with clinical features in newly diagnosed systemic lupus erythematosus].
Tao JH; Li XP; Li XM; Kan M; Zhai ZM; Wang W
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(43):3051-4. PubMed ID: 17288835
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of chemokines in acute myocardial infarction.
Kobusiak-Prokopowicz M; Orzeszko J; Mazur G; Mysiak A; Orda A; Mazurek W
Kardiol Pol; 2005 Apr; 62(4):301-14; discussion 315-6. PubMed ID: 15928736
[TBL] [Abstract][Full Text] [Related]
4. A rapid chemokine response of macrophage inflammatory protein (MIP)-1α, MIP-1β and the regulated on activation, normal T expressed and secreted chemokine is associated with a sustained virological response in the treatment of chronic hepatitis C.
Florholmen J; Kristiansen MG; Steigen SE; Sørbye SW; Paulssen EJ; Kvamme JM; Konopski Z; Gutteberg T; Goll R
Clin Microbiol Infect; 2011 Feb; 17(2):204-9. PubMed ID: 20219081
[TBL] [Abstract][Full Text] [Related]
5. Association of serum MIP-1alpha, MIP-1beta, and RANTES with clinical manifestations, disease activity, and damage accrual in systemic lupus erythematosus.
Vilá LM; Molina MJ; Mayor AM; Cruz JJ; Ríos-Olivares E; Ríos Z
Clin Rheumatol; 2007 May; 26(5):718-22. PubMed ID: 16924394
[TBL] [Abstract][Full Text] [Related]
6. Serum chemokine profile in patients with bullous pemphigoid.
Nakashima H; Fujimoto M; Asashima N; Watanabe R; Kuwano Y; Yazawa N; Maruyama N; Okochi H; Kumanogoh A; Tamaki K
Br J Dermatol; 2007 Mar; 156(3):454-9. PubMed ID: 17300233
[TBL] [Abstract][Full Text] [Related]
7. Lack of good correlation of serum CC-chemokine levels with human immunodeficiency virus-1 disease stage and response to treatment.
Ye P; Kazanjian P; Kunkel SL; Kirschner DE
J Lab Clin Med; 2004 May; 143(5):310-9. PubMed ID: 15122175
[TBL] [Abstract][Full Text] [Related]
8. Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis.
Crane IJ; McKillop-Smith S; Wallace CA; Lamont GR; Forrester JV
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1547-52. PubMed ID: 11381059
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers.
Rothenbacher D; Müller-Scholze S; Herder C; Koenig W; Kolb H
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):194-9. PubMed ID: 16239601
[TBL] [Abstract][Full Text] [Related]
10. Beta-chemokine function in experimental lung ischemia-reperfusion injury.
Krishnadasan B; Farivar AS; Naidu BV; Woolley SM; Byrne K; Fraga CH; Mulligan MS
Ann Thorac Surg; 2004 Mar; 77(3):1056-62. PubMed ID: 14992926
[TBL] [Abstract][Full Text] [Related]
11. Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with ebola virus secrete MIP-1alpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in vitro.
Gupta M; Mahanty S; Ahmed R; Rollin PE
Virology; 2001 May; 284(1):20-5. PubMed ID: 11352664
[TBL] [Abstract][Full Text] [Related]
12. Absence of favourable changes in circulating levels of interleukin-16 or beta-chemokine concentration following structured intermittent interruption treatment of chronic human immunodeficiency virus infection.
Montes de Oca Arjona M; Pérez Cano R; Orozco MJ; Martín Aspas A; Guerrero F; Fernández Gutiérrez Del Alamo C; Girón-González JA
Clin Microbiol Infect; 2005 Jan; 11(1):57-62. PubMed ID: 15649305
[TBL] [Abstract][Full Text] [Related]
13. Interaction between oxidative stress and chemokines: possible pathogenic role in systemic lupus erythematosus and rheumatoid arthritis.
Shah D; Wanchu A; Bhatnagar A
Immunobiology; 2011 Sep; 216(9):1010-7. PubMed ID: 21601309
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of the chemokine receptor, CCR5.
Mueller A; Mahmoud NG; Goedecke MC; McKeating JA; Strange PG
Br J Pharmacol; 2002 Feb; 135(4):1033-43. PubMed ID: 11861332
[TBL] [Abstract][Full Text] [Related]
15. Serum chemokines in patients with psoriatic arthritis treated with cyclosporin A.
Macchioni P; Boiardi L; Meliconi R; Pulsatelli L; Maldini MC; Ruggeri R; Facchini A; Salvarani C
J Rheumatol; 1998 Feb; 25(2):320-5. PubMed ID: 9489827
[TBL] [Abstract][Full Text] [Related]
16. Semiquantitative analysis of intrahepatic CC-chemokine mRNas in chronic hepatitis C.
Nischalke HD; Nattermann J; Fischer HP; Sauerbruch T; Spengler U; Dumoulin FL
Mediators Inflamm; 2004 Dec; 13(5-6):357-9. PubMed ID: 15770052
[TBL] [Abstract][Full Text] [Related]
17. Concentrations of macrophage inflammatory proteins MIP-1alpha and MIP-1beta and interleukin 8 (il-8) in lyme borreliosis.
Grygorczuk S; Pancewicz S; Zajkowska J; Kondrusik M; Rwierzbińska R; Hermanowska-Szpakowicz T
Infection; 2004 Dec; 32(6):350-5. PubMed ID: 15597225
[TBL] [Abstract][Full Text] [Related]
18. CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia.
Baier RJ; Majid A; Parupia H; Loggins J; Kruger TE
Pediatr Pulmonol; 2004 Feb; 37(2):137-48. PubMed ID: 14730659
[TBL] [Abstract][Full Text] [Related]
19. Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1.
Vicenzi E; Alfano M; Ghezzi S; Gatti A; Veglia F; Lazzarin A; Sozzani S; Mantovani A; Poli G
J Leukoc Biol; 2000 Sep; 68(3):405-12. PubMed ID: 10985258
[TBL] [Abstract][Full Text] [Related]
20. Highly active antiretroviral therapy normalizes the potential for MIP-1alpha production in HIV infection.
Carter LM; Peters BS; Ellis BA; Wolstencroft RA
J Infect; 2000 Nov; 41(3):252-5. PubMed ID: 11120614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
